Co-administration of sertraline and haloperidol

被引:9
|
作者
Lee, MS [1 ]
Han, CS [1 ]
Woonyou, Y [1 ]
Kim, SH [1 ]
机构
[1] Korea Univ, Coll Med, Dept Psychiat, Seoul 136701, South Korea
关键词
co-administration; haloperidol; reduced haloperidol; sertraline;
D O I
10.1111/j.1440-1819.1998.tb03220.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Along with recent increased interest in the selective serotonin reuptake inhibitors, a number of studies has been undertaken to observe interactions with different drugs. When selective serotonin reuptake inhibitor was administered together with antipsychotics to schizophrenics showing depressive or obsessive symptoms and negative symptoms, meaningful results were observed. The objective of our research was to identify the changes in the concentration of plasma haloperidol when sertraline was administered to patients who already were being treated with haloperidol. Sixteen patients who did not respond to die traditional antipsychotics after 2 weeks of treatment with a certain dosage of haloperidol were administered with 50 mg of sertraline for a period of 2 weeks. The concentration changes between plasma haloperidol and the reduced haloperidol were observed using high-powered liquid chromatography equipped with a UV detector. There was a significant increase (P < 0.01) in the concentration of haloperidol, the change being from 8.52 +/- 4.22 to 10.91 +/- 5.38 ng/mL. However, the change in the concentration of reduced haloperidol was from 7.41 +/- 7.93 to 5.22 +/- 6.10 ng/mL, showing a significant decrease. The concentrations of total plasma haloperidol showed no significant changes at all. In comparing the ratio of the reduced haloperidol and the haloperidol, the reduction ratio was down to 0.39 +/- 0.27 from 0.94 +/- 0.65 showing a significant decrease. There seems to be few studies done on interactions using serotonergic drugs together with antipsychotics in spite of their clinically applicable possibility. According to similar studies done in the past, co-administering of such drugs not only increases the plasma concentration of antipsychotics, but it also results ill clinical improvement of negative symptoms and aggravation of extrapyramidal symptoms. Changes in clinical symptoms and adverse effects were not observed in our study. However, we think these observations need to be included in upcoming larger scale studies.
引用
收藏
页码:S193 / S198
页数:6
相关论文
共 50 条
  • [1] Short-term co-administration of zolpidem and sertraline.
    Allard, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 106 - 106
  • [2] Sertraline with early alprazolam XR co-administration vs sertraline/placebo for panic disorder
    Goddard, AW
    Shekhar, A
    Rickels, K
    Rynn, M
    Janavs, J
    Sheehan, DV
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 44S - 45S
  • [3] Co-administration of haloperidol and drugs affecting the angiotensin pathway: effect on the extrapyramidal system
    Pemminati, Sudhakar
    Swati, B.
    Shreyasi, C.
    Gopalakrishna, H. N.
    Nair, Vinod
    Pai, M. R. S. M.
    TOXICOLOGY MECHANISMS AND METHODS, 2012, 22 (02) : 139 - 143
  • [4] Sertraline Co-administration Increases Olanzapine Clearance in People with Psychotic Depression - A Population Pharmacokinetic Analysis
    Davies, Simon J. C.
    Pollock, Bruce G.
    Kirshner, Margaret
    Meyers, Barnett S.
    Sorisio, Denise
    Mulsant, Benoit
    Whyte, Ellen M.
    Flint, Alastair J.
    Rothschild, Anthony J.
    Bies, Robert R.
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 124S - 125S
  • [5] The Impact of Sertraline Co-Administration on the Pharmacokinetics of Olanzapine: A Population Pharmacokinetic Analysis of the STOP-PD
    Davies, Simon J. C.
    Mulsant, Benoit H.
    Flint, Alastair J.
    Meyers, Barnett S.
    Rothschild, Anthony J.
    Whyte, Ellen M.
    Kirshner, Margaret M.
    Sorisio, Denise
    Pollock, Bruce G.
    Bies, Robert R.
    CLINICAL PHARMACOKINETICS, 2015, 54 (11) : 1161 - 1168
  • [6] The Impact of Sertraline Co-Administration on the Pharmacokinetics of Olanzapine: A Population Pharmacokinetic Analysis of the STOP-PD
    Simon J. C. Davies
    Benoit H. Mulsant
    Alastair J. Flint
    Barnett S. Meyers
    Anthony J. Rothschild
    Ellen M. Whyte
    Margaret M. Kirshner
    Denise Sorisio
    Bruce G. Pollock
    Robert R. Bies
    Clinical Pharmacokinetics, 2015, 54 : 1161 - 1168
  • [7] A randomized double-blind comparison of sertraline with early alprazolam XR Co-administration vs. sertraline/placebo for panic disorder
    Goddard, AW
    Ball, SG
    Hastings, AK
    Shekhar, A
    Rickels, K
    Rynn, M
    Janavs, J
    Sheehan, DV
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 62S - 62S
  • [8] Proteome analysis after co-administration of clozapine or haloperidol to MK-801-treated rats
    Paulson, L.
    Martin, P.
    Ljung, E.
    Blennow, K.
    Davidsson, P.
    JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (07) : 885 - 891
  • [9] Proteome analysis after co-administration of clozapine or haloperidol to MK-801-treated rats
    L. Paulson
    P. Martin
    E. Ljung
    K. Blennow
    P. Davidsson
    Journal of Neural Transmission, 2007, 114 : 885 - 891
  • [10] Disruption of latent inhibition induced by ovariectomy can be reversed by estradiol and clozapine as well as by co-administration of haloperidol with estradiol but not by haloperidol alone
    Arad, Michal
    Weiner, Ina
    PSYCHOPHARMACOLOGY, 2009, 206 (04) : 731 - 740